Literature DB >> 3699940

Pharmacokinetics of naproxen at two dosage regimens in healthy volunteers.

M J Franssen, Y Tan, L B van de Putte, C A van Ginneken, F W Gribnau.   

Abstract

The pharmacokinetic differences between two dosage regimens of naproxen (1000 mg once daily vs 500 mg twice daily) were studied at steady-state in seven healthy male volunteers. The twice daily regimen resulted in statistically significant higher trough serum levels, larger AUC0----24; also the time span with a concentration over 50 micrograms/ml was longer. The urinary excretion of naproxen metabolites was slightly greater upon once daily dosing. The VDextrap and, to a lesser extent the total body clearance, were larger upon the once daily regimen with a longer t1/2 beta as a consequence. As yet one can only speculate about the therapeutic implications of these findings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699940

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  2 in total

Review 1.  Clinical pharmacokinetics of naproxen.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

2.  Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.

Authors:  P Bertin; F Lapicque; E Payan; M Rigaud; F Bailleul; S Jaeger; R Treves; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.